3D Systems Corporation (DDD)

Over the past six months, 3D Systems' stock has been volatile. In November 2025, Q3 earnings missed projections, causing a stock drop due to a 19% year-over-year revenue decline. Positive developments included FDA clearance for its VSP Orthopedics platform and strategic investments in the Aerospace & Defense business, expecting over 20% growth in 2026. The company exchanged $30.77 million of convertible notes for 16.63 million shares and received FDA approval for 3D printed dentures. Despite a 90-day decline, the stock saw gains in the short term, but was still down approximately 23% over the last twelve months as of January 9, 2026.

Demand seasonality for 3D Systems is influenced by macroeconomic conditions and customer capital spending. While the company noted typical seasonal softness in Q3 2025, broader economic factors appear more significant. The Aerospace & Defense business is experiencing strong demand, as are healthcare solutions. The company's "razor-and-razor-blade" model suggests stable demand for consumables, with overall demand influenced more by industry-specific growth and the economic climate than pronounced seasonality.

3D Systems Corporation is a key player in additive manufacturing, offering 3D printing and digital manufacturing solutions like 3D printers, materials, software, and on-demand manufacturing services, primarily for industrial and healthcare sectors. The company operates in the Technology and Capital Goods sectors, spanning industries such as Computer Software, Industrial Machinery, Computer Hardware, and IT Services. Their offerings include diverse 3D printers using technologies like SLA, SLS, DMP, MJP, CJP, FDM, polymer extrusion, and bioprinting, along with a wide range of print materials and software platforms like 3D Sprint, 3DXpert, and Oqton. They also provide 3D printed parts, application engineering, 3D scanners, virtual surgical simulators, maintenance, training, and precision healthcare solutions.

Headquartered in Rock Hill, South Carolina, 3D Systems has a global presence, serving customers in 80 countries through subsidiaries and partners across North America, South America, Europe, the Middle East, Africa, Asia Pacific, and Oceania. Specific international locations include Leuven, France, Germany, Italy, Switzerland, South Korea, Brazil, the United Kingdom, China, and Japan, with a joint venture in Saudi Arabia. In the U.S., manufacturing includes system design in San Diego, next-generation printer manufacturing in Rock Hill, and certified metal parts production and advanced application development in Littleton, CO.

3D Systems' brand reputation is shaped by its focus on high-value markets like Healthcare and Aerospace & Defense. Strong growth in Aerospace & Defense and FDA clearances for medical solutions enhance its reputation. By 2027, it is expected to be the sole U.S. provider of a complete onshore metal additive manufacturing ecosystem. However, a difficult macroeconomic environment has led to cautious customer spending and declining revenue, with shares underperforming and revenue declining over the past few years, impacting its overall financial performance and brand perception.

Institutional investors hold approximately 60% to 62.10% of 3D Systems Corp. stock, with major holders including State Street Corp, BlackRock, Inc., Vanguard Group Inc, Capital World Investors, Morgan Stanley, D. E. Shaw & Co., Inc., and Geode Capital Management, Llc. Individual ownership includes Kevin S. Moore with 4.14% and G. Walter Loewenbaum II with 3.94%. The CEO, Jeffrey Graves, holds 0.9% of shares. Retail investors hold an estimated 21.95% to 55.01% of the company's stock.